ProBioGen is a Berlin-based contract development and manufacturing organisation (CDMO) specialising in cell line engineering, process development, and GMP manufacturing for biopharmaceuticals. Founded in 1994, the company combines cutting-edge technologies with expert services to accelerate drug development and production.

Key Products and Services

• Cell line engineering and process development
• GMP manufacturing for therapeutic proteins and viruses
• Biosimilars and biobetters development
• Advanced analytics and bioassays
• Proprietary technologies: GlymaxX® ADCC enhancement, viral vector platforms, and Lenti.RiGHT®

With a focus on innovation and precision, ProBioGen partners with clients globally to transform drug candidates into market-ready therapies.